Trademark: 87367210
Word
TUVEP
Status
Dead
Status Code
710
Status Date
Friday, April 19, 2024
Serial Number
87367210
Registration Number
5300911
Registration Date
Tuesday, October 3, 2017
Mark Type
4
Filing Date
Friday, March 10, 2017
Published for Opposition
Tuesday, July 18, 2017
Cancellation Date
Friday, April 19, 2024

Trademark Owner History
Glaxo Group Limited - Original Registrant

Classifications
5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Trademark Events
Jun 5, 2017
Assigned To Examiner
Jun 8, 2017
Approved For Pub - Principal Register
Jul 18, 2017
Published For Opposition
Jul 18, 2017
Official Gazette Publication Confirmation E-Mailed
Oct 3, 2017
Registered-Principal Register
Oct 3, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Nov 9, 2022
Teas Change Of Owner Address Received
Nov 9, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 9, 2022
Teas Change Of Correspondence Received
Mar 14, 2017
New Application Entered
Mar 16, 2017
New Application Office Supplied Data Entered
Jun 28, 2017
Notification Of Notice Of Publication E-Mailed
Nov 9, 2022
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 9, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 19, 2024
Cancelled Sec. 8 (6-Yr)

Trademark Alertz updated from USPTO on 2030-01-24